The Compounding Tortoise

The Compounding Tortoise

Q3 2025 - Topicus

As expected, top-line benefited from Cipal acquisition but far more pressure on EBITA

The Compounding Tortoise's avatar
The Compounding Tortoise
Nov 05, 2025
∙ Paid

Yesterday, after the bell, Topicus reported its Q3 results.

While the top-line growth was solid with +24% (o/w 3% organic), we’d like to remind our readers of the already anticipated accretion from Cipal Schaubroeck. As shared in our Q2 recap, we cautioned against the near-term EBITA margin dilution.

Q2/1H 2025 - Topicus.com - Analysis

Q2/1H 2025 - Topicus.com - Analysis

The Compounding Tortoise
·
August 2, 2025
Read full story

Below the surface, though, Q3 performance was softer than expected with like-for-like (excluding earn-out revaluations) EBITA margin contracting 220 bps. This was driven solely by Cipal Schaubroeck (acquired early June 2025), offset by continued momentum at Sygnity and the lack of Q2 acquisitions leading to one-time closing costs.

Let’s take a closer look at the report and the puts and takes.

FIY: Lumine also came through with its earnings report, which we’ll cover this weekend in the full CSI recap, including an updated valuation picture.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 The Compounding Tortoise · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture